scholarly journals Endovascular Treatment of Type A Aortic Dissection

2020 ◽  
Vol 4 (2) ◽  
pp. 51-58
Author(s):  
Ivo Petrov ◽  
Zoran Stankov ◽  
Gloria Adam
2020 ◽  
Vol 72 (3) ◽  
pp. e316-e317
Author(s):  
Andrew David Wisneski ◽  
Vishal Kumar ◽  
Shant Vartanian ◽  
Adam Z. Oskowitz

Vessel Plus ◽  
2020 ◽  
Vol 2020 ◽  
Author(s):  
Ting Wei Chang ◽  
Ting Ting Yang ◽  
Hong Jie Jhou ◽  
Liang Ying Ke ◽  
Ying Fu Chen

2020 ◽  
pp. 021849232092921
Author(s):  
Maximilian Kreibich ◽  
Bartosz Rylski ◽  
Friedhelm Beyersdorf ◽  
Matthias Siepe ◽  
Martin Czerny

The endovascular treatment of pathologies of the ascending aorta has not been incorporated into routine clinical practice. The aim of this article is to provide an overview of the endovascular treatment of pathologies of the ascending aorta, particularly type A aortic dissection. A thorough analysis and discussion of anatomical, physiological, clinical and technical challenges, and obstacles is performed. Conventional straight stent-grafts alone are not capable of fixing the entire complex underlying problem in the vast majority of patients with acute type A aortic dissection. An endovascular valve-carrying conduit consisting of a proximal transcatheter aortic valve connected to a covered stent-graft would be able to close a primary entry tear in the ascending aorta, ensure coronary perfusion, initiate true lumen expansion, treat malperfusion, treat aortic regurgitation, drain any pericardial effusion through a transapical approach, and possibly stabilize the distal aorta. Two thirds of all patients with acute aortic dissection are potential candidates for endovascular treatment, and the concept may help to significantly improve survival in patients with acute aortic dissection.


2018 ◽  
Vol 4 ◽  
pp. 69-69 ◽  
Author(s):  
Maximilian Kreibich ◽  
Bartosz Rylski ◽  
Stoyan Kondov ◽  
Julia Morlock ◽  
Johannes Scheumann ◽  
...  

2019 ◽  
Vol 29 (6) ◽  
pp. 978-980 ◽  
Author(s):  
Isaac Wamala ◽  
Roland Heck ◽  
Volkmar Falk ◽  
Semih Buz

Abstract Endovascular treatment is a viable alternative therapy in high-risk patients with acute type A aortic dissection. However, the optimal endovascular treatment strategy is still evolving. Herein, we present a case of a 91-year-old man who successfully underwent repair of an ascending aortic dissection using a stent-in-stent technique. At 1-year follow-up, the stent demonstrated repair durability.


2011 ◽  
Vol 18 (3) ◽  
pp. 368-373 ◽  
Author(s):  
Gabriele Iannelli ◽  
Luigi Di Tommaso ◽  
Plinio Cirillo ◽  
Raffaele Smimmo ◽  
Federico Piscione ◽  
...  

Author(s):  
Jacob Budtz-Lilly ◽  
Per Vikholm ◽  
Anders Wanhainen ◽  
Rafael Astudillo ◽  
Stefan Thelin ◽  
...  

2020 ◽  
Vol 59 (1) ◽  
pp. 80-91
Author(s):  
Changtian Wang ◽  
Ludwig Karl von Segesser ◽  
Francesco Maisano ◽  
Enrico Ferrari

Summary OBJECTIVES Type A aortic dissection requires immediate surgical repair. Despite improvements in surgery and anaesthesia, there is still a considerable risk when high-risk patients are concerned. Less invasive endovascular treatments are under evaluation. We investigated the current status of catheter-based treatment for type A aortic dissection with the entry tear located in the ascending aorta. METHODS A PubMed search was supplemented by searching through bibliographies and key articles. Demographics, risk score, stent graft detail, access route, mortality, cause of death, complications, reinterventions and follow-up data were extracted and analysed. RESULTS Thirty-one articles (7 retrospective reports; 24 case reports/series) were included in the study. In total, 104 patients (mean age 71 ± 14 years) received endovascular treatment for acute (63) or chronic (41) type A dissection. A history of a major cardiac or aortic operation was present in 29 patients. The mean EuroSCORE II was 30 ± 20 in 4 reports. A total of 114 stent grafts were implanted: ‘off-the-shelf’, 65/114; custom made, 12/114; and modified, 7/114. Hospital complications included intraprocedural conversion to open surgery (2/104), stroke (2/104), coronary stenting (2/104), early endoleak (9/104) and repeat aortic endovascular treatment for endoleak (5/104). Hospital mortality was 10% (intraoperative death 2/104). Mean duration of follow-up time was 21 ± 21 months (range 1–81 months); follow-up data were available for 86 patients: 10 patients died of non-aortic-related causes; reintervention for aortic disease (endovascular repair or open surgery) was performed in 8 patients. CONCLUSIONS Catheter-based ascending aorta repair for type A aortic dissection with the entry tear in the ascending aorta can be considered in carefully selected high-risk patients. Further analysis and specifically designed devices are required.


Sign in / Sign up

Export Citation Format

Share Document